Ghost Cells as a Two-Phase Blood Analog Fluid-Optical Thrombus Growth Detection Using Particle Image Velocimetry
- PMID: 40530441
- DOI: 10.1111/aor.15042
Ghost Cells as a Two-Phase Blood Analog Fluid-Optical Thrombus Growth Detection Using Particle Image Velocimetry
Abstract
Background: In vitro thrombosis tests for mechanical circulatory support systems lack standardized ISO guidelines. A major limitation of current approaches is the absence of continuous thrombus monitoring, as terminated experiments at a single time point fail to capture the dynamic nature of thrombus formation. However, spatially resolved thrombus formation and its underlying dynamics are crucial for the optimization of mechanical circulatory support systems.
Methods: In this study, we present a high-resolution thrombus monitoring approach using particle image velocimetry with a thrombogenic, two-phase blood analog fluid, designated as "ghost blood". Ghost blood consists of plasma and ghost cells, which are hemoglobin-depleted erythrocytes. We validate and quantify the particle image velocimetry with ghost blood and use this combination to monitor thrombus growth.
Results: The validation demonstrated velocity fields in the FDA-pump are consistent with existing literature, confirming the usability of ghost blood in particle image velocimetry. The use range of ghost blood is quantified as a formula to determine the maximum possible optical penetration depth. Finally, thrombus growth was successfully monitored in the FDA-pump.
Conclusion: In this proof of principle study, we grew a thrombus in the FDA-pump and were able to monitor its growth from a first thrombus thread to a complete obstruction of the flow. This approach enables both the localization and the temporal growth of the thrombus to be visualized and thereby provides a foundation for future advancements in thrombosis assessment and the optimization of mechanical circulatory support systems.
Keywords: particle image velocimetry; resealed ghost cells; thrombus growth monitoring; translucent two‐phase blood analog fluid.
© 2025 The Author(s). Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
References
-
- ISO 10993‐4:2017, Biological Evaluation of Medical Devices—Part 4: Selection of Tests for Interactions With Blood 1099.
-
- M. K. Brockhaus, M. J. Behbahani, F. Muris, et al., “In Vitro Thrombogenicity Testing of Pulsatile Mechanical Circulatory Support Systems: Design and Proof‐Of‐Concept,” Artificial Organs 45, no. 12 (2021): 1513–1521.
-
- C. H. H. Chan, D. Nandakumar, N. Balletti, et al., “In Vitro Hemocompatibility Evaluation of Modified Rotary Left to Right Ventricular Assist Devices in Pulmonary Flow Conditions,” ASAIO Journal 66, no. 6 (2020): 637–644.
-
- S. M. Hastings, S. R. Deshpande, S. Wagoner, K. Maher, and D. N. Ku, “Thrombosis in Centrifugal Pumps: Location and Composition in Clinical and In Vitro Circuits,” International Journal of Artificial Organs 39, no. 4 (2016): 200–204.
-
- O. Maruyama, Y. Tomari, D. Sugiyama, M. Nishida, T. Tsutsui, and T. Yamane, “Simple In Vitro Testing Method for Antithrombogenic Evaluation of Centrifugal Blood Pumps,” ASAIO Journal 55, no. 4 (2009): 314–322.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
